Newlink Genetics reported $-7720000 in Pre-Tax Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US $ -50.6M 17M
Bristol Myers Squibb BMY:US $ 5386M 595M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Celldex Therapeutics CLDX:US $ -23.05M 2.9M
Idera Pharmaceuticals IDRA:US $ -4.18M 0.06M
Intrexon XON:US $ -19.31M 5.71M
Merk MRK:US $ 6309M 1525M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Newlink Genetics NLNK:US $ -7.72M 1.44M
Pfizer PFE:US $ 11328M 4083M
Prothena PRTA:US $ -37.96M 4.86M
Sarepta Therapeutics SRPT:US $ -104.15M 17.74M
Vascular Biogenics VBLT:US -10428000 1.32M
YTE INCY:US $ 172.84M 1.75M